Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (191-200 of 285) with videos related to

Pageof 29
Sort By:
Magnetic Resonance in Medicine|January 19, 2019
Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patientsEdzo M E Klawer, Petra J van Houdt, Frank F J Simonis, et al.
Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.
Magnetic Resonance in Medicine|December 22, 2020
Erratum to: Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients (Magn Reson Med. 2019; 81: 3358-3369)Edzo M E Klawer, Petra J van Houdt, Frank F J Simonis, et al.
Oncotarget|March 26, 2016
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1Lien Spans, Thomas Van den Broeck, Elien Smeets, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 8, 2019
Histopathological Features of MRI-Invisible Regions of Prostate Cancer LesionsPetra J van Houdt, Ghazaleh Ghobadi, Ivo G Schoots, et al.
Medical Physics|January 1, 2017
Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledgeCuong Viet Dinh, Peter Steenbergen, Ghazaleh Ghobadi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Young onset rectal cancer (YORC): a descriptive tertiary center analysisCédric Schraepen, Gertjan Rasschaert, Pieter Maerten, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 2012
Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluationWilly J M de Kruijf, Jan Verstraete, David Neustadter, et al.
JMIR Research Protocols|December 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II TrialCédric Draulans, Steven Joniau, Valérie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imagingRuud G P M van Stiphout, Guido Lammering, Jeroen Buijsen, et al.
Pageof 29

Showing results (191-200 of 285) with videos related to

Sort By:
Pageof 29
Magnetic Resonance in Medicine|January 19, 2019
Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patientsEdzo M E Klawer, Petra J van Houdt, Frank F J Simonis, et al.
Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.
Magnetic Resonance in Medicine|December 22, 2020
Erratum to: Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients (Magn Reson Med. 2019; 81: 3358-3369)Edzo M E Klawer, Petra J van Houdt, Frank F J Simonis, et al.
Oncotarget|March 26, 2016
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1Lien Spans, Thomas Van den Broeck, Elien Smeets, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 8, 2019
Histopathological Features of MRI-Invisible Regions of Prostate Cancer LesionsPetra J van Houdt, Ghazaleh Ghobadi, Ivo G Schoots, et al.
Medical Physics|January 1, 2017
Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledgeCuong Viet Dinh, Peter Steenbergen, Ghazaleh Ghobadi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2026
Young onset rectal cancer (YORC): a descriptive tertiary center analysisCédric Schraepen, Gertjan Rasschaert, Pieter Maerten, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 2012
Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluationWilly J M de Kruijf, Jan Verstraete, David Neustadter, et al.
JMIR Research Protocols|December 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II TrialCédric Draulans, Steven Joniau, Valérie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imagingRuud G P M van Stiphout, Guido Lammering, Jeroen Buijsen, et al.
Pageof 29